CR Double-Crane Pharmaceuticals Co., Ltd (“CR Double-Crane”) announced that it was authorized solely to develop, manufacture and commercialize Novita Pharmaceuticals, Inc.’s (“Novita Pharmaceuticals”) new target Fascin protein inhibitor NP-G2-044 in the Greater China Region (Mainland China, Hong Kong, Macau and Taiwan) on 21 July. An online signing ceremony was held on the same day.

On 8 July 2021, the delegation led by First Secretary of the Embassy of the Democratic Republic of the Congo in China Jock visited CR Pharmaceutical Holdings (“CR Pharma”) to exchange views and ideas on diagnostic reagents export business, and to understand CR Pharma’s diagnostic reagent business as well as its capability to export products so as to lay the foundation for mutually beneficial collaboration in future.

On 3 November 2020, Guangxi China Resources Building, a new landmark in Guangxi meticulously built by China Resources Land (“CR Land”), was officially completed. On the same day, the RUN HK Guangxi-Hong Kong Industrial Innovation Centre and the Hong Kong Youth (Mainland) Entrepreneurship Service Centre held an unveiling ceremony in the Guangxi China Resources Building where both centres are housed. CY Leung, Vice Chairman of the National Committee of the Chinese People's Political Consultative Conference (“CPPCC”), Sun Dawei, Party Secretary of the CPPCC Committee of Guangxi Zhuang Autonomous Region, and Pan Jiarong, Chairman of the Hong Kong (Region) Chamber of Commerce in China-Guangxi (“HKCCC”) attended the ceremony.

On 5 September 2020, in celebration of the fifth Charity Day of China, China Resources launched the "Healthy Village" philanthropic initiative with the theme of "Caring for Primary Health and Building a Healthy China" in Beijing. Adhering to the "Healthy China 2030 Planning Outline" and "China Women (and Children) Development Outline", the project aims to implement the rural revitalization strategy.

Hang Seng Indexes Company Limited (“Hang Seng Indexes”) recently announced the results of its review of the Hang Seng Family of Indexes for the quarter ended 30 June 2020. For the first time, CR Power is included as a constituent in both the HSI ESG 50 Index and Hang Seng Corporate Sustainability Benchmark Index.

CR Power was ranked 7th as a Pace-Setter among 67 companies in the first Greater Bay Area Business Sustainability Index (“GBABSI”) jointly launched by the Chinese University of Hong Kong (“CUHK”) Business School’s Centre for Business Sustainability (“CBS”), CUHK and SGS Hong Kong on 24 July 2020.

Hang Seng Indexes Company Limited (“Hang Seng Indexes”) has recently launched the HSI ESG 50 Index to reflect the performance of top 50 ESG leaders with relatively high market-capitalization listed in Hong Kong. CR Land is included in the ESG 50 Index based on a comprehensive assessment of its ESG performance by Hang Seng Indexes.

On 28 June 2020, CR Cement announced the brand valuation report presented by the World Brand Lab on its proprietary brand Runfeng Cement. According to the report, Runfeng Cement’s 2020 brand value reached RMB51.958 billion.

On 27 May 2020, CR Capital and CR Land jointly organized the unveiling ceremony for CR Capital Tower in Shenzhen with China Resources Group General Manager Wang Xiangming officiating at the ceremony.

On 12 May 2020, CR Gas announced to place a total of 90 million shares at a price of HK$40.81 per share in the capital market through placing of existing shares and top-up subscription for new shares. The placing price represented a 7.14% discount to the closing price in the last trading day of the announcement and a 4.69% discount to average closing price of the past 5 trading days. The shares placed represented approximately 4.05% of the issued share capital of the Company and approximately 3.89% of the Company’s issued share capital as enlarged by the Subscription. Goldman Sachs was the sole placing agent.